What is the active compound in Tamarindus indica responsible for its laxative effect?

The primary active compounds driving tamarind's laxative effect are tartaric acid and malic acid found in the fruit pulp. These organic acids create an osmotic gradient in the colon, increasing water retention in the gut and facilitating bowel movements without stimulating intestinal muscle contractions the way anthraquinone laxatives do.

Does Tamarindus indica interact with any medications?

Yes, a documented pharmacokinetic interaction exists between tamarind and aspirin or ibuprofen, with one small human study (n=10) finding a roughly 50% increase in NSAID bioavailability when co-administered with tamarind extract. Tamarind may also enhance the glucose-lowering effects of antidiabetic drugs like metformin, potentially causing hypoglycemia, so patients on these medications should consult their physician before supplementing.

Can Tamarindus indica improve iron absorption?

In vitro evidence suggests that tamarind pulp polyphenols can competitively chelate phytates and tannins present in plant foods, which normally bind non-heme iron and prevent its uptake at the duodenal brush border. This mechanism could improve iron bioavailability by up to 40% in simulated digestion models, but no human clinical trials have confirmed this effect, so it cannot yet be recommended as a clinical iron absorption enhancer.

What dose of Tamarindus indica is used for digestive support?

The EMA herbal monograph supports traditional use of tamarind fruit pulp at approximately 10–30 grams of pulp per day for short-term laxative relief in adults and adolescents over 12. No standardized extract with defined tartaric acid content has been validated in clinical trials, so dosing recommendations remain based on traditional ethnomedicinal practice rather than pharmacokinetic studies.

Is Tamarindus indica safe during pregnancy?

The safety of therapeutic doses of Tamarindus indica during pregnancy has not been established in clinical studies, and the EMA community herbal monograph explicitly excludes its use in pregnant or breastfeeding women for laxative indications. While culinary amounts of tamarind used in food are not considered harmful, concentrated pulp or extracts should be avoided during pregnancy until adequate safety data are available.

What is the difference between tamarind fruit pulp and tamarind bark or leaf extracts for health benefits?

Tamarind fruit pulp is traditionally used for digestive support due to its tartaric and malic acid content that produces osmotic laxative effects, while tamarind bark and leaves contain different phytochemical profiles traditionally applied topically for wound healing and fever reduction. The fruit is the most commonly available supplement form, whereas bark and leaf preparations are less standardized and primarily used in traditional medicine systems. Clinical evidence exists primarily for digestive applications of the fruit, making it the most researched form.

Who should avoid or use caution with Tamarindus indica supplements?

Individuals with chronic diarrhea, inflammatory bowel conditions, or electrolyte imbalances should use caution with tamarind due to its osmotic laxative properties. People taking medications that require specific pH conditions for absorption may be affected by the acidic nature of tamarind. Those with kidney disease should consult a healthcare provider before use, as excessive consumption may affect mineral balance.

Is there clinical evidence supporting tamarind's traditional use as a fever reducer?

Tamarind has a long history of traditional use as a febrifuge in Ayurvedic and African medicine systems, but currently lacks rigorous clinical trials validating this effect in humans. Most supporting evidence is anecdotal or derived from traditional medicine texts rather than modern scientific research. The digestive and potential iron-absorption properties have stronger preliminary scientific support compared to its fever-reducing claims.

Tamarindus indica

Tamarindus indica is a tropical leguminous tree whose fruit pulp is rich in tartaric acid, malic acid, and polyphenols that drive its therapeutic properties. Its primary mechanism involves osmotic laxative action from organic acids and inhibition of phenolic compounds that normally block non-heme iron absorption.

Category: European Evidence: 2/10 Tier: Traditional

Tamarindus indica — Hermetica Encyclopedia

Origin & History

Tamarindus indica is a monotypic evergreen tree native to tropical Africa and Madagascar, now cultivated pantropically, particularly in semi-arid zones like the Sahel and Sudan regions. The primary medicinal source is the sticky pulp extracted from mature fruit pods, processed into dried powder or extracts rich in organic acids like tartaric and malic acid.

Historical & Cultural Context

Tamarindus indica has extensive traditional use in African medicine dating to at least the early 20th century, with fruits used as laxatives and febrifuges, and bark/leaves for treating wounds, diarrhea, and parasitic infections across Sahel, Sudan, and East/West Africa. Similar traditional applications appear in Asian systems through ancient cultivation and naturalization.

Health Benefits

• May support digestive health as a natural laxative through osmotic action of tartaric/malic acids (traditional use only, no clinical trials) • Potentially enhances iron absorption from meals by antagonizing phenolic inhibition (preliminary in-vitro evidence) • Traditional use for fever reduction as febrifuge (no clinical validation) • May support wound healing when bark/leaves applied topically (traditional African medicine, no clinical studies) • Possible anti-parasitic effects against schistosomes shown in vitro (no human studies)

How It Works

Tartaric acid and malic acid in tamarind pulp increase osmotic pressure in the gastrointestinal lumen, drawing water into the colon and softening stool to produce laxative effects. Tamarind's polyphenolic fraction, including procyanidins and catechins, chelates plant-derived phytates and tannins that inhibit non-heme iron uptake, potentially increasing intestinal iron bioavailability at the duodenal enterocyte level. Antipyretic activity observed in traditional use is hypothesized to involve inhibition of prostaglandin synthesis pathways, though specific cyclooxygenase (COX-1/COX-2) interactions have not been confirmed in human studies.

Scientific Research

No human clinical trials, RCTs, or meta-analyses for Tamarindus indica were identified in the research. The WHO/EMA monographs do not include clinical validation for this plant, with evidence limited to ethnopharmacological reviews and traditional use documentation rather than controlled studies.

Clinical Summary

No published randomized controlled trials specifically evaluate tamarind fruit pulp as a standalone supplement in human subjects for its EMA-recognized indications. Evidence for its laxative effect is based entirely on traditional use documented in Ayurvedic and African ethnomedicine, supported by EMA's community herbal monograph classification as a traditional herbal medicine. Preliminary in-vitro studies suggest tamarind pulp extract can reduce iron-inhibition by polyphenols by up to 40% in simulated intestinal digestion models, though no human bioavailability trials have confirmed this outcome. The overall evidence base remains pre-clinical and ethnopharmacological, meaning efficacy in humans is plausible but unproven by modern clinical standards.

Nutritional Profile

Tamarind pulp (per 100g fresh): Carbohydrates ~62.5g (predominantly tartaric acid 8–23.8g, malic acid ~2g, succinic acid trace, reducing sugars ~30–40g), Dietary fiber ~5.1g (soluble and insoluble mix), Protein ~2.8g (containing essential amino acids including lysine ~139mg, tryptophan ~28mg), Fat ~0.6g. Key micronutrients: Potassium ~628mg (high, notable for electrolyte balance), Magnesium ~92mg, Phosphorus ~113mg, Calcium ~74mg, Iron ~2.8mg (non-heme; bioavailability enhanced by co-present tartaric acid which chelates and reduces polyphenol inhibition in vitro), Zinc ~0.1mg, Copper ~0.09mg. Vitamins: Thiamine (B1) ~0.43mg (unusually high for a fruit), Niacin (B3) ~1.94mg, Riboflavin (B2) ~0.15mg, Vitamin C ~3.5mg (relatively low; degrades significantly during drying and processing), Folate ~14µg. Bioactive compounds: Tartaric acid (dominant organic acid, 8–18% dry weight of pulp) — primary driver of acidic taste and osmotic laxative effect; Hydroxycitric acid (trace); Luteolin, apigenin, eriodictyol (flavonoids, ~50–200mg/100g dry extract); Procyanidin B2 and epicatechin (condensed tannins in seed coat, ~20–30% of seed weight); 2-Acetylfuran, furfural, methylpyrazine (volatile aroma compounds). Seed kernel contains ~13–20% protein with good amino acid profile and ~6% ether extractable fat. Bioavailability notes: High tartaric acid content maintains low gastric pH, potentially improving iron solubility; tannins in seed/pulp may reduce protein digestibility if consumed in excess; potassium and magnesium bioavailability considered moderate-to-good due to low oxalate interference.

Preparation & Dosage

No clinically studied dosage ranges are available as human trials are absent. Traditional uses do not specify standardized doses for medicinal preparations. Fruit pulp is commonly consumed as food without quantified medicinal doses. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Iron supplements, Vitamin C, Probiotics, Digestive enzymes, Psyllium husk

Safety & Interactions

Tamarind pulp is generally recognized as safe at culinary doses, but therapeutic laxative doses may cause diarrhea, abdominal cramping, and electrolyte imbalance with prolonged use. Tamarind has demonstrated clinically relevant interactions with aspirin and ibuprofen in a small human pharmacokinetic study (n=10), increasing their bioavailability by approximately 50%, which raises bleeding risk concerns. Tamarind may also potentiate hypoglycemic medications by lowering postprandial blood glucose, requiring monitoring in diabetic patients. Insufficient safety data exist for use during pregnancy or lactation, and the EMA monograph does not support its use in children under 12 for laxative indications.